Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease

Drug Delivery and Translational Research
Rajkumar MalayandiDeepika Aggarwal

Abstract

Colon targeted dosage forms have been extensively studied for the localized treatment of inflammatory bowel disease. These dosage forms not only improve the therapeutic efficacy but also reduce the incidence of adverse drug reactions and hence improve the patient compliance. However, complex and highly variable gastro intestinal physiology limits the clinical success of these dosage forms. Biopharmaceutical characteristics of these dosage forms play a key role in rapid formulation development and ensure the clinical success. The complexity in product development and clinical success of colon targeted dosage forms are based on the biopharmaceutical characteristics such as physicochemical properties of drug substances, pharmaceutical characteristics of dosage form, physiological conditions and pharmacokinetic properties of drug substances as well as drug products. Various in vitro and in vivo techniques have been employed in past to characterize the biopharmaceutical properties of colon targeted dosage forms. This review focuses on the factors influencing the biopharmaceutical performances of the dosage forms, in vitro characterization techniques and in vivo studies.

References

Mar 1, 1978·Applied and Environmental Microbiology·K T ChungM Egan
Oct 1, 1977·Journal of Bacteriology·E P Greenberg, E Canale-Parola
Sep 1, 1976·Journal of Pharmaceutical Sciences·D L CaseyM B Shabhu
Dec 1, 1976·Gut·H S Wiggins, J H Cummings
Jun 1, 1992·Digestive Diseases and Sciences·T S Gaginella, R E Walsh
Jan 1, 1992·The Journal of Applied Bacteriology·G T MacfarlaneJ H Cummings
May 1, 1991·Journal of Pediatric Gastroenterology and Nutrition·J S HyamsJ T Boyle
Jun 1, 1991·The Journal of Applied Bacteriology·J H Cummings, G T Macfarlane
Jan 1, 1990·The Medical Clinics of North America·L R Sutherland
Jul 1, 1990·The Journal of Pharmacy and Pharmacology·J E DevereuxM B Short
Nov 1, 1990·The Journal of International Medical Research·A E CoreyJ D Conklin
Jan 1, 1991·Canadian Journal of Physiology and Pharmacology·J H Cummings, H N Englyst
Apr 1, 1991·Applied and Environmental Microbiology·F RafilC E Cerniglia
Jul 1, 1990·Applied and Environmental Microbiology·F RafiiC E Cerniglia
Aug 1, 1990·Biopharmaceutics & Drug Disposition·A Rubinstein
Jul 1, 1990·Pharmaceutical Research·J B DressmanK M Jarvenpaa
Dec 1, 1989·Alimentary Pharmacology & Therapeutics·J FallingborgH H Rasmussen
Mar 1, 1989·Applied and Environmental Microbiology·S A GibsonG T MacFarlane
Dec 1, 1985·The Journal of Pharmacy and Pharmacology·J G HardyE Wood
May 1, 1987·The American Journal of Clinical Nutrition·J H Cummings, H N Englyst
Jan 1, 1988·Drug Metabolism Reviews·I R Rowland
Sep 1, 1987·Clinical Pharmacokinetics·J M Cedarbaum
Dec 24, 1987·The New England Journal of Medicine·K W SchroederD M Ilstrup
Jan 1, 1988·Applied and Environmental Microbiology·B W ManningC E Cerniglia
Jun 1, 1988·Journal of Biomedical Materials Research·B D RatnerT A Horbett
Jun 4, 1966·Lancet·G H GriffithR Shields
Nov 1, 1971·Journal of Medical Microbiology·G HawksworthM J Hill
Mar 8, 1980·Lancet·R F Harvey, J M Bradshaw
May 1, 1980·The New England Journal of Medicine·D H PresentB S Pasternack
Apr 1, 1982·British Journal of Clinical Pharmacology·A K AzadkhanJ K Aronson
Jan 1, 1984·Clinical Neuropharmacology·J G Nutt, J H Fellman
Apr 15, 1983·Science·J R SahaJ Lindenbaum
Apr 1, 1980·Gut·P A van HeesJ H van Tongeren
May 1, 1993·Applied Microbiology and Biotechnology·K MollyW Verstraete
Nov 1, 1993·Journal of Pharmaceutical Sciences·H H Blume, K K Midha

❮ Previous
Next ❯

Citations

Jun 14, 2015·AAPS PharmSciTech·Seth AmidonVivek S Dave
May 17, 2018·The Journal of Pharmacy and Pharmacology·Angela EffingerNikoletta Fotaki
Jul 22, 2014·Artificial Cells, Nanomedicine, and Biotechnology·Baljeet SinghGoutam Rath
Apr 12, 2020·Drug Delivery and Translational Research·Neha Desai, Munira Momin
Jan 29, 2020·Archives of Pharmacal Research·Muhammad NaeemJin-Wook Yoo
Mar 13, 2020·Frontiers in Pharmacology·Pramila ChaubeySujata Sawarkar
Feb 1, 2020·Advanced Pharmaceutical Bulletin·Sharon Kunnath JosephSreeja Chandrasekharan Nair

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Edmund S KostewiczJennifer Dressman
Journal of Pharmaceutical Sciences
Harikrishna DevalapallyMansoor M Amiji
Canadian Medical Association Journal
M Pernarowski
© 2021 Meta ULC. All rights reserved